MedTrace Logo

RCT of Brief Universal Parenting Program to Prevent Child Behavioural and Emotional Difficulties in Greece

NCT02030730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2014-01-08

No results posted yet for this study

Summary

This study investigates the impact of a Triple P Seminar Series on positive parenting for universal prevention of behavioural and emotional difficulties in a general Greek sample of parents with children aged 2 to 12. It is predicted that, compared to an attention control condition, parents randomised to the Seminar Series will report lower levels of children's disruptive and emotional difficulties at post-intervention. At the same time, it is postulated that parents will show a decrease in dysfunctional discipline styles, greater feelings of self-efficacy as well as lower levels of distress. Lastly, it is hypothesized that the effects observed at post-intervention will remain at the 6-month follow-up.

Conditions

  • Child Behavior Disorders
  • Parenting

Interventions

BEHAVIORAL

Triple P Seminar Series

The intervention was delivered by the researcher and an accredited TripleP practitioner. The seminars took place in a conference room located within a bookshop. The seminars were re-offered for parents who could not attend the scheduled day.

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Konstantinos Foskolos · University of Oxford

  • Frances Gardner · University of Oxford

  • Paul Montgomery · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-03-31
Completion
2013-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02030730 on ClinicalTrials.gov